Neha Manpuria
Stock Analyst at Bank of America Securities
(2.66)
# 2,769
Out of 4,356 analysts
19
Total ratings
71.4%
Success rate
5.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Neha Manpuria
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: DRREDDY Dr. Reddy's Laboratories Limited | Reiterated: Buy | ₹1,620 → ₹1,600 | $1,303.50 | +22.75% | 2 | Dec 15, 2025 | |
| NSE: ALKEM Alkem Laboratories Limited | Upgraded: Hold | ₹5,530 | $5,498.00 | +0.58% | 1 | Aug 13, 2025 | |
| NSE: LUPIN Lupin Limited | Upgraded: Hold | ₹1,930 → ₹1,970 | $2,267.70 | -13.13% | 2 | Aug 8, 2025 | |
| NSE: CIPLA Cipla Limited | Maintained: Sell | ₹1,420 → ₹1,500 | $1,401.00 | +7.07% | 2 | Jul 27, 2025 | |
| NSE: AUROPHARMA Aurobindo Pharma Limited | Maintained: Buy | ₹1,350 | $1,426.40 | n/a | 1 | May 27, 2025 | |
| NSE: MANKIND Mankind Pharma Limited | Maintained: Sell | ₹2,150 | $2,375.60 | n/a | 1 | May 21, 2025 | |
| NSE: MAXHEALTH Max Healthcare Institute Limited | Maintained: Hold | ₹1,170 | $965.10 | n/a | 1 | May 21, 2025 | |
| NSE: DIVISLAB Divi's Laboratories Limited | Maintained: Buy | ₹7,150 | $6,667.00 | n/a | 1 | May 19, 2025 | |
| NSE: APOLLOHOSP Apollo Hospitals Enterprise Limited | Maintained: Buy | ₹8,150 | $8,176.50 | n/a | 1 | Feb 11, 2025 | |
| NSE: GLAND Gland Pharma Limited | Maintained: Buy | ₹2,020 | $2,250.00 | n/a | 1 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,940 | $1,799.20 | n/a | 1 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $19 | $13.63 | n/a | 5 | Jan 17, 2025 |
Dr. Reddy's Laboratories Limited
Dec 15, 2025
Reiterated: Buy
Price Target: ₹1,620 → ₹1,600
Current: $1,303.50
Upside: +22.75%
Alkem Laboratories Limited
Aug 13, 2025
Upgraded: Hold
Price Target: ₹5,530
Current: $5,498.00
Upside: +0.58%
Lupin Limited
Aug 8, 2025
Upgraded: Hold
Price Target: ₹1,930 → ₹1,970
Current: $2,267.70
Upside: -13.13%
Cipla Limited
Jul 27, 2025
Maintained: Sell
Price Target: ₹1,420 → ₹1,500
Current: $1,401.00
Upside: +7.07%
Aurobindo Pharma Limited
May 27, 2025
Maintained: Buy
Price Target: ₹1,350
Current: $1,426.40
Upside: n/a
Mankind Pharma Limited
May 21, 2025
Maintained: Sell
Price Target: ₹2,150
Current: $2,375.60
Upside: n/a
Max Healthcare Institute Limited
May 21, 2025
Maintained: Hold
Price Target: ₹1,170
Current: $965.10
Upside: n/a
Divi's Laboratories Limited
May 19, 2025
Maintained: Buy
Price Target: ₹7,150
Current: $6,667.00
Upside: n/a
Apollo Hospitals Enterprise Limited
Feb 11, 2025
Maintained: Buy
Price Target: ₹8,150
Current: $8,176.50
Upside: n/a
Gland Pharma Limited
Feb 4, 2025
Maintained: Buy
Price Target: ₹2,020
Current: $2,250.00
Upside: n/a
Jan 31, 2025
Maintained: Hold
Price Target: ₹1,940
Current: $1,799.20
Upside: n/a
Jan 17, 2025
Reiterated: Buy
Price Target: $18 → $19
Current: $13.63
Upside: n/a